Suspension of trading
Oncternal Therapeutics, Inc. Stock
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2024-12-02 EST
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 25-07-01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 25-07-01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 1.56M 1.38M 1.29M 1.18M 2.22M 150M 2.24M 15.64M 6.06M 76.59M 5.85M 5.72M 246M | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -32.38M -28.77M -26.85M -24.47M -46.16M -3.11B -46.59M -325M -126M -1.59B -122M -119M -5.11B | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 89.8 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 2017-03-31 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 2023-06-30 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Dan Kisner
BRD | Director/Board Member | 79 | 2019-06-06 |
William LaRue
BRD | Director/Board Member | 75 | 2017-11-30 |
Xin Nakanishi
BRD | Director/Board Member | 64 | 2018-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/20/24 | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 | Free | Director | 2,200 | 0.0743% | ||
| 6/20/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.23% | 1.56M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -3.11% | -3.53% | +20.19% | +81.44% | 57.39B | |
| +0.89% | -0.63% | +2.17% | +36.19% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +742.40% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +35.38% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +105.50% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.97B | |
| -2.68% | +2.92% | +29.33% | +22.72% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -11.37% | 24.34B | |
| Average | -2.61% | -3.11% | +47.37% | +106.56% | 39.05B | |
| Weighted average by Cap. | +0.12% | -0.84% | +56.96% | +138.26% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.49M 1.32M 1.24M 1.13M 2.12M 143M 2.14M 14.95M 5.79M 73.23M 5.59M 5.47M 235M | 785K 697K 651K 593K 1.12M 75.46M 1.13M 7.88M 3.05M 38.58M 2.95M 2.88M 124M |
| Net income | -44.17M -39.25M -36.63M -33.39M -62.97M -4.25B -63.55M -443M -172M -2.17B -166M -162M -6.97B | -39.48M -35.08M -32.74M -29.84M -56.28M -3.8B -56.8M -396M -154M -1.94B -148M -145M -6.23B |
| Net Debt | -63.64M -56.54M -52.77M -48.1M -90.72M -6.12B -91.56M -639M -247M -3.13B -239M -234M -10.04B | -33.94M -30.15M -28.14M -25.65M -48.38M -3.26B -48.83M -341M -132M -1.67B -127M -125M -5.35B |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
